Vaccine for monkey pox proves highly effective – CDC

A monkey pox vaccine with a high level of effectiveness has been approved by the CDC and offers protection for two weeks after the first injection.

Vaccinated people a 14-fold lower risk of acquiring monkey pox during the period between July 31 and September 3, compared to unvaccinated people.

Infections confirmed in 32 jurisdictions across the country, according to the results.

In the current outbreak, which began in May this year, more than 25,000 people affected, primarily men who have had sex with men.

“We’re cautiously optimistic the vaccine will work as intended based on these new data,” CDC head Rochelle Walensky said.

Even with these promising results, we recommend that people receive two doses of Jynneos vaccine separated by 28 days to ensure durable, lasting immunity to monkey pox.

Human Immune response on Monkey pox vaccine

Jynneos vaccine against monkey pox yet to evaluated for effectiveness. Since prior studies only examined animals and measured human immune responses.

Its estimated that over 66,000 cases of monkey pox detected around the world, but new infections fallen since August.

There over 680,000 patients vaccinated with the Jynneos vaccine in the United States who are gay, bisexual, transgender, and gender diverse.

Demetre Daskalakis, the deputy coordinator for the White House monkeypox response. Said the vaccination would now offer to people without prior exposure, rather than after a known exposure.

New strategy allow people for vaccination

According to him, this new strategy may now allow more people to be eligible for the monkeypox vaccination as a result of this new strategy.

Rather than administering the vaccine to the forearm, health providers allowed to administer it to the shoulder or upper back in order to reduce stigma.

“We’re cautiously optimistic the vaccine will work as intended based on these new data,” CDC head Rochelle Walensky said.